Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Genome Res ; 20(7): 972-80, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20488932

ABSTRACT

Abnormalities of genomic methylation patterns are lethal or cause disease, but the cues that normally designate CpG dinucleotides for methylation are poorly understood. We have developed a new method of methylation profiling that has single-CpG resolution and can address the methylation status of repeated sequences. We have used this method to determine the methylation status of >275 million CpG sites in human and mouse DNA from breast and brain tissues. Methylation density at most sequences was found to increase linearly with CpG density and to fall sharply at very high CpG densities, but transposons remained densely methylated even at higher CpG densities. The presence of histone H2A.Z and histone H3 di- or trimethylated at lysine 4 correlated strongly with unmethylated DNA and occurred primarily at promoter regions. We conclude that methylation is the default state of most CpG dinucleotides in the mammalian genome and that a combination of local dinucleotide frequencies, the interaction of repeated sequences, and the presence or absence of histone variants or modifications shields a population of CpG sites (most of which are in and around promoters) from DNA methyltransferases that lack intrinsic sequence specificity.


Subject(s)
Base Sequence/physiology , Chromatin/chemistry , Chromatin/physiology , DNA Methylation , Animals , Brain/metabolism , Breast/metabolism , Chromatin/genetics , Chromosome Mapping , CpG Islands/genetics , Female , Genome , Histones/metabolism , Humans , Mice , Sequence Analysis, DNA , Validation Studies as Topic
2.
Learn Mem ; 14(7): 504-11, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17644752

ABSTRACT

Following learning, a memory is fragile and undergoes a protein synthesis-dependent consolidation process in order to become stable. Established memories can again become transiently sensitive to disruption if reactivated and require another protein synthesis-dependent process, known as reconsolidation, in order to persist. Here, we show that, in the basolateral amygdala (BLA), protein synthesis is necessary for both consolidation and reconsolidation of inhibitory avoidance (IA) memory, while the expression of the transcription factor CCAAT enhancer binding protein beta (C/EBPbeta) is essential only for the reconsolidation process. Moreover, the critical roles of both protein synthesis and C/EBPbeta following IA reactivation are temporally restricted, as they are necessary only for recent but not old IA memories. These results, together with previous findings showing that in the hippocampus both protein synthesis and C/EBPbeta expression are required for consolidation but not reconsolidation of IA indicate that the stabilization process that takes place either after training or memory retrieval engages distinct neural circuits. Within these circuits, the C/EBPbeta-dependent molecular pathway appears to be differentially recruited.


Subject(s)
Amygdala/physiology , Avoidance Learning/physiology , CCAAT-Enhancer-Binding Protein-beta/genetics , CCAAT-Enhancer-Binding Protein-beta/metabolism , Inhibition, Psychological , Animals , Anisomycin/pharmacology , Avoidance Learning/drug effects , Electroshock , Male , Memory/drug effects , Memory/physiology , Nucleic Acid Synthesis Inhibitors/pharmacology , Oligodeoxyribonucleotides/pharmacology , Rats , Rats, Long-Evans , Time Factors
3.
J Neurosci ; 26(11): 3010-20, 2006 Mar 15.
Article in English | MEDLINE | ID: mdl-16540579

ABSTRACT

In human addicts, craving and relapse are frequently evoked by the recall of memories connected to a drug experience. Established memories can become labile if recalled and can then be disrupted by several interfering events and pharmacological treatments, including inhibition of protein synthesis. Thus, reactivation of mnemonic traces provides an opportunity for disrupting memories that contribute to pathological states. Here, we tested whether the memory of a drug experience can be weakened by inhibiting protein synthesis after the reactivation of its trace. We found that an established morphine conditioned place preference (mCPP) was persistently disrupted if protein synthesis was blocked by either anisomycin or cycloheximide after the representation of a conditioning session. Unlike other types of memories, an established mCPP did not become labile after contextual recall, but required the concomitant re-experience of both the conditioning context and the drug. An established mCPP was disrupted after the conditioning session if protein synthesis was blocked selectively in the hippocampus, basolateral amygdala, or nucleus accumbens but not in the ventral tegmental area. This disruption seems to be permanent, because the preference did not return after further conditioning. Thus, established memories induced by a drug of abuse can be persistently disrupted after reactivation of the conditioning experience.


Subject(s)
Anisomycin/pharmacology , Association Learning/drug effects , Conditioning, Classical/drug effects , Cycloheximide/pharmacology , Mental Recall/drug effects , Morphine/pharmacology , Protein Synthesis Inhibitors/pharmacology , Spatial Behavior/drug effects , Amnesia, Retrograde/chemically induced , Amnesia, Retrograde/metabolism , Amygdala/drug effects , Amygdala/metabolism , Amygdala/physiopathology , Animals , Anisomycin/administration & dosage , Association Learning/physiology , Conditioning, Classical/physiology , Cues , Cycloheximide/administration & dosage , Hippocampus/drug effects , Hippocampus/metabolism , Hippocampus/physiopathology , Learning , Male , Mental Recall/physiology , Microinjections , Morphine/toxicity , Morphine Dependence/physiopathology , Morphine Dependence/psychology , Nerve Tissue Proteins/biosynthesis , Nerve Tissue Proteins/physiology , Nucleus Accumbens/drug effects , Nucleus Accumbens/metabolism , Nucleus Accumbens/physiopathology , Organ Specificity , Protein Synthesis Inhibitors/administration & dosage , Rats , Rats, Long-Evans , Reward , Time Factors , Ventral Tegmental Area/drug effects , Ventral Tegmental Area/metabolism , Ventral Tegmental Area/physiopathology
4.
PLoS Biol ; 3(9): e293, 2005 Sep.
Article in English | MEDLINE | ID: mdl-16104829

ABSTRACT

A new memory is initially labile and becomes stabilized through a process of consolidation, which depends on gene expression. Stable memories, however, can again become labile if reactivated by recall and require another phase of protein synthesis in order to be maintained. This process is known as reconsolidation. The functional significance of the labile phase of reconsolidation is unknown; one hypothesis proposes that it is required to link new information with reactivated memories. Reconsolidation is distinct from the initial consolidation, and one distinction is that the requirement for specific proteins or general protein synthesis during the two processes occurs in different brain areas. Here, we identified an anatomically distinctive molecular requirement that doubly dissociates consolidation from reconsolidation of an inhibitory avoidance memory. We then used this requirement to investigate whether reconsolidation and consolidation are involved in linking new information with reactivated memories. In contrast to what the hypothesis predicted, we found that reconsolidation does not contribute to the formation of an association between new and reactivated information. Instead, it recruits mechanisms similar to those underlying consolidation of a new memory. Thus, linking new information to a reactivated memory is mediated by consolidation and not reconsolidation mechanisms.


Subject(s)
Avoidance Learning/drug effects , Conditioning, Classical/drug effects , Memory/physiology , Mental Recall/physiology , Amygdala/drug effects , Amygdala/physiology , Animals , Anisomycin/pharmacology , Avoidance Learning/physiology , Conditioning, Classical/physiology , Hippocampus/drug effects , Hippocampus/metabolism , Memory/drug effects , Mental Recall/drug effects , Models, Neurological , Protein Synthesis Inhibitors/pharmacology , Rats , Rats, Long-Evans
5.
Neuron ; 36(3): 521-5, 2002 Oct 24.
Article in English | MEDLINE | ID: mdl-12408853

ABSTRACT

Learning of new information is transformed into long-lasting memory through a process known as consolidation, which requires protein synthesis. Classical theory held that once consolidated, memory was insensitive to disruption. However, old memories that are insensitive to protein synthesis inhibitors can become vulnerable if they are recalled (reactivated). These findings led to a new hypothesis that when an old memory is reactivated, it again becomes labile and, similar to a newly formed memory, requires a process of reconsolidation in order to be maintained. Here, we show that the requirement for protein synthesis of a reactivated memory is evident only when the memory is recent. In fact, memory vulnerability decreases as the time between the original training and the recall increases.


Subject(s)
Brain/metabolism , Learning/physiology , Memory Disorders/metabolism , Memory/physiology , Nerve Tissue Proteins/biosynthesis , Reaction Time/physiology , Amygdala/drug effects , Amygdala/metabolism , Animals , Anisomycin/pharmacology , Brain/drug effects , Hippocampus/drug effects , Hippocampus/metabolism , Learning/drug effects , Male , Memory/drug effects , Memory Disorders/chemically induced , Memory Disorders/physiopathology , Nerve Tissue Proteins/antagonists & inhibitors , Neural Pathways/drug effects , Neural Pathways/metabolism , Protein Synthesis Inhibitors/pharmacology , Rats , Rats, Long-Evans , Reaction Time/drug effects , Synapses/drug effects , Synapses/metabolism , Synaptic Transmission/drug effects , Synaptic Transmission/physiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL